What is ABECMA? ABECMA (idecabtagene vicleucel) is a prescription medicine for the treatment of multiple myeloma in patients who have received at least four kinds of treatment regimens that have not worked or have stopped working. ABECMA is a medicine made from your own white blood cells; the cells are genetically modified to recognize and attack your multiple myeloma cells.

This website is best viewed using the horizontal display on your tablet device.

This website is best viewed using the vertical display on your mobile device.

FOR ADULTS WITH RELAPSED OR
REFRACTORY MULTIPLE MYELOMA (MM)

CHANGING
MY
STORY

STARTS WITH

ABECMA® is a CAR T cell therapy made from your own immune cells that have been reprogrammed to help fight your MM* in a one-time infusion.

Talk to your doctor today and discover what is possible with ABECMA.

*ABECMA can also target normal, healthy cells.

The treatment process includes blood collection, CAR T cell creation, administration, and adverse event monitoring.

Is ABECMA right for me?

Learn about some factors you and your doctor should consider when determining if ABECMA is right for you.

Not an actual patient.

How ABECMA can help

See results from a clinical trial of adults with relapsed or refractory MM.

Not an actual patient.

Cell Therapy 360®: Your partner throughout the CAR T cell therapy treatment journey

Resources designed to support you and your caregiver throughout the treatment journey.